Morning Briefing
Summaries of health policy coverage from major news organizations
Pharma In Asia-Pacific Region Becomes More Active In R&D, Study Finds
In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
